AstraZeneca's Big US Stock Move: London's Loss?

AstraZeneca's Wall Street move: Is this the beginning of the end for London's financial dominance? The pharmaceutical giant is listing directly on the NYSE, raising fears that more UK companies will follow, lured by America's booming stock market. Will London lose its biggest players, or can it hold its own as a global financial hub? Hosted on Acast. See acast.com/privacy for more information.